Axon Enterprise Inc

AXON

Equity

ISIN null / Valor 36372319

NASDAQ (2026-06-04)

USD 513.20+6.59%

Axon Enterprise Inc
UMushroom community rating:

4.40 3 votes No rating yet

NegativeNeutralPositive

About company

Axon Enterprise, Inc. is a publicly traded technology company (Nasdaq: AAXN) that supplies hardware, software and cloud services to law enforcement and public safety agencies worldwide; its product lineup includes conducted-energy devices (TASER devices), body-worn and in‑vehicle cameras, and related peripherals, while its software offerings — notably a cloud-based digital evidence management platform and analytics/redaction tools — create recurring subscription revenue and enable agencies to store, manage and review audio, video and other incident data. The company bundles device sales with training, support and services and has expanded into adjacent areas such as integrated evidence workflows, AI-assisted analysis and aerial systems, positioning itself as a provider of end-to-end hardware-plus-software solutions for policing and public safety.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-34.2%1Y

166%3Y

264%5Y

Performance

53.3%1Y

47.8%3Y

47.1%5Y

Volatility

41365 M

Market cap (USD)

1,287,665

Daily traded volume (Shares)

606.76 / 592.17

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.40

3 votes

Performance:

4.40

Innovation:

4.40

Society:

4.40

Nature:

4.40

Alex Van Der Valk

United Kingdom, 05 Nov 2025

I feel the market has over-reacted to the latest earnings results, and will bounce back. If the US government shutdown ends soon, I suspect that this will accelerate the recovery for Axon.